FNY Investment Advisers LLC acquired a new position in OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 105,690 shares of the biotechnology company’s stock, valued at approximately $272,000. FNY Investment Advisers LLC owned approximately 3.56% of […]
StockNews.com began coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research note published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. OncoSec Medical Stock Performance Shares of NASDAQ ONCS opened at $0.21 on Friday. The stock has a fifty day moving average price of $0.65 […]
By Chris Wack OncoSec Medical shares were down 55% at 19 cents after the company said in a filing to the Securities and Exchange Commission it was filing for.
U.S. stocks traded higher midway through trading, with Dow Jones gaining more than 300 points on Thursday. The Dow traded up 0.98% to 34,313.85 while the NASDAQ rose 0.73% to 13,726.16. The S&P 500, also rose, gaining, 0.81% to 4,408.03.